Merck's promising results fuel expectations for Indian partners
Drug-maker approaching USFDA for emergency approval as soon as possible04-10-2021
04-10-2021
Divi's Labs shares up 7 percent after Merck pill raises hope for COVID patients
The company is an authorised manufacturer of Molnupiravir, Merck's antiviral pill that halves the chances of hospitalisation or death among most at risk of contracting COVID-1904-10-2021
Merck's Covid pill results raise hopes for developing world
Potentially, the drug could be very cheap to manufacture and available at a low cost in developing nations, benefiting millions of people02-10-2021
Merck to buy Acceleron Pharma for $11.5 billion
Pharmaceutical giant enhances its rare-disease business with a bet on treatments for respiratory and blood diseases30-09-2021
Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from October 1, 2021 until 48 hours from the publication of the unaudited financial results for quarter ended September 30, 2021. Kindly take the same on record.30-09-2021
Pfizer begins study of oral drug for prevention of COVID-19
The company and its rivals, including U.S.-based Merck Co Inc and Swiss pharmaceutical Roche Holding AG, have been racing to develop the first antiviral pill for COVID-19.27-09-2021
Procter & Gamble Health Ltd - 500126 - Related Party Transactions For Six Months Ended June 30, 2021
We are enclosing herewith the Related Party Transactions for six months ended June 30, 2021. Kindly take the same on record and oblige.25-09-2021
Procter & Gamble Health Ltd - 500126 - Appointment Of Dr. Elizabeth Desmond As Non-Executive Director
we refer to our letter dated August 26, 2021 informing that Dr. Elizabeth Desmond had been appointed as an Additional (Non-Executive) Director of the Company subject to and effective from date of allotment of Director Identification Number. We would like to inform you that, Dr. Elizabeth Desmond has been allotted DIN 09333010 by the Ministry of Corporate Affairs on September 24, 2021. Consequently, Dr. Elizabeth Desmond's appointment as an Additional Director (Non-Executive) is effective from September 24, 202124-09-2021
Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Change in Directorate
We refer to our letter dated August 26, 2021 informing that Dr. Elizabeth Desmond had been appointed as an Additional (Non-Executive) Director of the Company subject to and effective from date of allotment of Director Identification Number. We would like to inform you that, Dr. Elizabeth Desmond has been allotted DIN 09333010 by the Ministry of Corporate Affairs on September 24, 2021. Consequently, Dr. Elizabeth Desmond's appointment as an Additional Director (Non-Executive) is effective from September 24, 2021. Kindly take the same on record and oblige.24-09-2021
Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Resignation of Director
In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Mr. Sujay Wasan, Non-Executive Director has tendered his resignation as the Director of the Company effective close of business hours of September 23, 2021. Kindly take the same on record and oblige.24-09-2021